Welcome to our dedicated page for ORACLE SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oracle Corp. filings document the formal disclosure record for its enterprise software, database, cloud infrastructure, and cloud application business. Current reports cover quarterly operating and financial results, cloud revenue categories, dividends on common stock and mandatory convertible preferred stock, and the company’s NYSE-listed common stock and depositary shares.
Oracle’s SEC record also includes proxy and 8-K disclosures on board composition, executive appointments, compensation arrangements, annual meeting voting matters, material agreements, capital-structure matters, and other material events tied to corporate governance and financial reporting.
Oracle director Rona Fairhead reported routine equity compensation activity involving restricted stock units. On May 31, 2026, 2,114 restricted stock units were converted into 2,114 shares of Oracle common stock, and 58 shares were withheld at $225.78 per share to cover tax liabilities on vesting.
She also received a grant of 1,550 new restricted stock units, which vest 100% on the first anniversary of the grant date. Following these transactions, Fairhead directly holds 24,166 shares of Oracle common stock, in addition to indirect holdings for three children of 3,861, 3,720, and 3,694 shares, respectively.
Oracle Corp director Bruce R. Chizen reported routine equity compensation activity with no open-market trades. He exercised 2,114 restricted stock units into 2,114 shares of common stock, increasing his directly held common stock to 71,056 shares. He also received a new grant of 1,550 restricted stock units, each representing the right to receive one share of common stock at settlement and scheduled to vest 100% on the first anniversary of the grant date. In addition, 13,169 shares of common stock are reported as held indirectly through a trust.
Oracle director Michael J. Boskin reported routine equity compensation activity. He exercised restricted stock units covering 2,114 shares of Oracle common stock, bringing his directly held common stock to 97,558 shares. He also received a new grant of 1,550 restricted stock units, which each convert into one share and vest 100% on the first anniversary of the grant date. In addition, 1,000 shares of common stock are reported as held indirectly through his spouse.
Oracle Corp director Jeffrey Berg reported routine equity compensation changes. He exercised 2,114 restricted stock units, which converted into 2,114 shares of Oracle common stock held indirectly through The Berg Family Trust, bringing that trust’s indirect common stock holdings to 154,113 shares.
He also received a new grant of 1,550 restricted stock units, all held directly, each representing one future share of common stock at settlement. The filing notes an additional indirect holding of 1,450 common shares held by his spouse and includes a correction to previously reported indirect beneficial ownership from an earlier Form 4.
Oracle Corp director Ablo Awo reported routine equity compensation activity involving restricted stock units. On May 31, 2026, 2,114 restricted stock units were exercised into the same number of common shares, and 80 shares of common stock were withheld at $225.78 per share to cover tax obligations.
On the same date, Awo also received a new grant of 1,550 restricted stock units, each representing the right to receive one share of Oracle common stock at settlement. These units vest 100% on the first anniversary of the grant date, reflecting standard time-based vesting rather than an open-market transaction.
Oracle Corp filed an initial SEC ownership report for director Tomislav Mihaljevic on Form 3. The insider data shows no reported transactions, with zero buys, sells, gifts, or derivative exercises and a neutral net buy/sell position.
Oracle Corporation has elected Dr. Tomislav Mihaljevic to its Board of Directors, effective May 6, 2026, and increased the Board size to 13 members. He is Chief Executive Officer and President of Cleveland Clinic and has led the organization since January 2018.
Dr. Mihaljevic will receive restricted stock units in Oracle common stock on May 31, 2026 under the company’s directors’ stock plan, with full vesting on the first anniversary of the grant if he continues serving as a director. He will also receive standard cash compensation for non-employee directors and has entered into Oracle’s standard indemnification agreement. Board members serve one-year terms and will next stand for election at the annual meeting in November 2026.
Oracle Corporation Chief Financial Officer Hilary B. Maxson received new equity awards. On May 5, 2026, she was granted 56,111 restricted stock units and stock options on 224,441 shares of common stock at an exercise price of $185.35 per share.
The stock options vest 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029, and 10% on May 5, 2030, and expire on May 5, 2036, subject to continued employment through each vesting date. The restricted stock units follow the same 40/30/20/10 vesting schedule and each unit represents the right to receive one share of common stock at settlement.
Oracle Corporation executive vice president and chief legal officer Stuart Levey acquired 346.321 restricted stock units in the form of dividend equivalents tied to previously earned RSUs granted on November 5, 2022. The dividend equivalents were calculated using Oracle’s closing stock price of $173.28 on April 24, 2026, and increase his directly held equity-based position to 159,841.303 units of common-stock-settled awards. This is a compensation-related grant, not an open‑market trade.
ORACLE CORP executive vice president and chief legal officer Stuart Levey reported an open-market sale of 15,000 shares of Oracle common stock at an average price of $176.19 per share. After this transaction, he directly holds 3,429 shares. The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026, indicating it was scheduled in advance rather than timed discretionarily.